Valuation West Pharmaceutical Services, Inc. Berne S.E.
Stocks
WPS
US9553061055
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Berne S.E.
2026-09-03
|
5-day change | 1st Jan Change | ||
| 275.76 CHF | -0.70% |
|
-2.09% | - |
| 09-01 | Oncology firm Novocure says cyberattack exposed US patient records | RE |
| 08-26 | Boston Scientific hit by cyberattack, global operations affected | RE |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 24,120 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 21.85% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 23,617 | 23,081 | 22,661 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 22.96% | -2.27% | -1.82% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 40x | 34.7x | 31x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 7.7x | 6.72x | 5.95x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.5x | 2.3x | 2.6x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.15x | 6.72x | 6.26x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7x | 6.43x | 5.88x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 25.1x | 22.2x | 19.6x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 31.2x | 27.2x | 23.8x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 54.8x | 40.7x | 31.3x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.82% | 2.46% | 3.2% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.9025 | 0.9729 | 1.121 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.26% | 0.28% | 0.33% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.575 | 9.865 | 11.04 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.5% | 9.86% | 10.2% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,375 | 3,587 | 3,854 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 940.4 | 1,041 | 1,159 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 757.5 | 848.4 | 952.3 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 614.5 | 701.2 | 778 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -503.3 | -1,039 | -1,458 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 342.73 | 342.73 | 342.73 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,376 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 31.21x | 4.22x | 16.21x | 2.36% | 188B | |
| 19.69x | 3.59x | 12.84x | 3.05% | 119B | |
| 18.47x | 0.21x | 13.42x | 0.71% | 64.35B | |
| 29.98x | 7.39x | 19.09x | 1.33% | 52.59B | |
| 36.16x | 3.47x | 11.9x | 2.09% | 51.11B | |
| 35.96x | 6.33x | 19.86x | -.--% | 33.85B | |
| 47.24x | 1.35x | 12.52x | 0.2% | 32.1B | |
| 39.97x | 7x | 25.11x | 0.26% | 24.12B | |
| 18.39x | 2.93x | 10.38x | 1.5% | 23.39B | |
| Average | 30.78x | 4.06x | 15.70x | 1.28% | 65.44B | |
| Weighted average by Cap. | 28.80x | 3.90x | 15.25x | 1.83% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- WPS Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
